148 related articles for article (PubMed ID: 9075807)
1. Nitric oxide and ocular blood flow in patients with IDDM.
Schmetterer L; Findl O; Fasching P; Ferber W; Strenn K; Breiteneder H; Adam H; Eichler HG; Wolzt M
Diabetes; 1997 Apr; 46(4):653-8. PubMed ID: 9075807
[TBL] [Abstract][Full Text] [Related]
2. The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
Dorner GT; Garhöfer G; Selenko N; Fasching P; Bayerle-Eder M; Schmetterer L; Wolzt M
Graefes Arch Clin Exp Ophthalmol; 2003 Aug; 241(8):619-24. PubMed ID: 12836035
[TBL] [Abstract][Full Text] [Related]
3. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man.
Schmetterer L; Krejcy K; Kastner J; Wolzt M; Gouya G; Findl O; Lexer F; Breiteneder H; Fercher AF; Eichler HG
Exp Eye Res; 1997 Mar; 64(3):305-12. PubMed ID: 9196381
[TBL] [Abstract][Full Text] [Related]
4. Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans.
Schmetterer L; Findl O; Strenn K; Graselli U; Kastner J; Eichler HG; Wolzt M
Am J Physiol; 1997 Dec; 273(6):R2005-12. PubMed ID: 9435655
[TBL] [Abstract][Full Text] [Related]
5. Effects of adrenomedullin on ocular hemodynamic parameters in the choroid and the ophthalmic artery.
Dorner GT; Garhöfer G; Huemer KH; Golestani E; Zawinka C; Schmetterer L; Wolzt M
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3947-51. PubMed ID: 12939313
[TBL] [Abstract][Full Text] [Related]
6. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects.
Luksch A; Polak K; Beier C; Polska E; Wolzt M; Dorner GT; Eichler HG; Schmetterer L
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3080-4. PubMed ID: 10967067
[TBL] [Abstract][Full Text] [Related]
7. Renal and ocular hemodynamic effects of insulin.
Schmetterer L; Müller M; Fasching P; Diepolder C; Gallenkamp A; Zanaschka G; Findl O; Strenn K; Mensik C; Tschernko E; Eichler HG; Wolzt M
Diabetes; 1997 Nov; 46(11):1868-74. PubMed ID: 9356038
[TBL] [Abstract][Full Text] [Related]
8. Acetazolamide-induced cerebral and ocular vasodilation in humans is independent of nitric oxide.
Kiss B; Dallinger S; Findl O; Rainer G; Eichler HG; Schmetterer L
Am J Physiol; 1999 Jun; 276(6):R1661-7. PubMed ID: 10362745
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
[TBL] [Abstract][Full Text] [Related]
10. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of N(G)-monomethyl-L-arginine into humans are dose dependent.
Lepori M; Sartori C; Trueb L; Owlya R; Nicod P; Scherrer U
J Hypertens; 1998 Apr; 16(4):519-23. PubMed ID: 9797197
[TBL] [Abstract][Full Text] [Related]
11. Altered nitric oxide system in patients with open-angle glaucoma.
Polak K; Luksch A; Berisha F; Fuchsjaeger-Mayrl G; Dallinger S; Schmetterer L
Arch Ophthalmol; 2007 Apr; 125(4):494-8. PubMed ID: 17420369
[TBL] [Abstract][Full Text] [Related]
12. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus.
Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD
Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937
[TBL] [Abstract][Full Text] [Related]
14. Contribution of nitric oxide to the blood pressure and arterial responses to exercise in humans.
Campbell R; Fisher JP; Sharman JE; McDonnell BJ; Frenneaux MP
J Hum Hypertens; 2011 Apr; 25(4):262-70. PubMed ID: 20505750
[TBL] [Abstract][Full Text] [Related]
15. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
Hjorth Lassen L; Klingenberg Iversen H; Olesen J
Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
[TBL] [Abstract][Full Text] [Related]
16. Characterization of local vascular effects of the nitric oxide inhibitor NG-monomethyl-L-arginine on dorsal hand veins.
Schindler C; Leuschner S; Schwanebeck U; Kirch W
J Clin Pharmacol; 2012 Jun; 52(6):859-69. PubMed ID: 21566204
[TBL] [Abstract][Full Text] [Related]
17. Role of NO in the control of choroidal blood flow during a decrease in ocular perfusion pressure.
Simader C; Lung S; Weigert G; Kolodjaschna J; Fuchsjäger-Mayrl G; Schmetterer L; Polska E
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):372-7. PubMed ID: 19124845
[TBL] [Abstract][Full Text] [Related]
18. Effect of nitric oxide synthase inhibition on renal hemodynamics in humans: reversal by L-arginine.
Wolzt M; Schmetterer L; Ferber W; Artner E; Mensik C; Eichler HG; Krejcy K
Am J Physiol; 1997 Feb; 272(2 Pt 2):F178-82. PubMed ID: 9124393
[TBL] [Abstract][Full Text] [Related]
19. Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans.
Luksch A; Polska E; Imhof A; Schering J; Fuchsjäger-Mayrl G; Wolzt M; Schmetterer L
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):734-9. PubMed ID: 12556406
[TBL] [Abstract][Full Text] [Related]
20. C-peptide does not affect ocular blood flow in patients with type 1 diabetes.
Polska E; Kolodjaschna J; Berisha F; Malec MM; Simader C; Bayerle-Eder M; Roden M; Schmetterer L
Diabetes Care; 2006 Sep; 29(9):2034-8. PubMed ID: 16936149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
